Cart
sales@molnova.com
Fenpropidin
CAS No. 67306-00-7
Fenpropidin( —— )
Catalog No. M27311 CAS No. 67306-00-7
Fenpropidin, a fungicide, is a specific inhibitor of sterol 14-reductase and biosynthesis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 29 | In Stock |
|
| 10MG | 46 | In Stock |
|
| 25MG | 61 | In Stock |
|
| 50MG | 72 | In Stock |
|
| 100MG | 114 | In Stock |
|
| 200MG | 166 | In Stock |
|
| 500MG | 276 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFenpropidin
-
NoteResearch use only, not for human use.
-
Brief DescriptionFenpropidin, a fungicide, is a specific inhibitor of sterol 14-reductase and biosynthesis.
-
DescriptionFenpropidin, a fungicide, is a specific inhibitor of sterol 14-reductase and biosynthesis.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number67306-00-7
-
Formula Weight273.464
-
Molecular FormulaC19H31N
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (365.68 mM)
-
SMILESCC(CN1CCCCC1)Cc1ccc(cc1)C(C)(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Matthew B Wright, et al. Compounds targeting OSBPL7 increase ABCA1-dependent cholesterol efflux preserving kidney function in two models of kidney disease. Nat Commun. 2021 Aug 2;12(1):4662.
molnova catalog
related products
-
KKL-40
A small-molecule inhibitor of bacterial ribosome rescue that exhibits broad-spectrum antimicrobial activity against bacteria grown in liquid culture.
-
Xyloidone
Xyloidone exhibits antifungal activity and completely inhibits the mycelial growth of B. cinerea, Colletotrichum acutatum Simmonds, Colletotrichum gloeosporioides Simmonds, M. grisea, and Pythium ultimum Trow over a range of 0.4-33.3 mg/L.
-
Norlichexanthone
Norlichexanthone has the potential to treat and/or prevent lifestyle-related diseases such as type 2 diabetes, metabolic syndrome, atherosclerosis and cardiovascular disease.
